Security key
501147102
Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS)
CUSIP: 501147102
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, $0.00001 par value ("Common Stock")
- Shares outstanding
- 29,463,330
- Total 13F shares
- 24,418,337
- Share change
- +328,798
- Total reported value
- $3,029,453,570
- Put/Call ratio
- 216%
- Price per share
- $124.06
- Number of holders
- 194
- Value change
- +$42,716,131
- Number of buys
- 92
- Number of sells
- 86
Report period
Q4 2023
Institutions
194
Top holders
10
KRYS full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Krystal Biotech, Inc. SEC filings
Krystal Biotech, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 501147102
Recent filing periods:
Top shareholders of KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
8.9%
|
2,629,383
|
$305,008,428 | — | 30 Sep 2023 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
8.7%
|
2,565,555
|
$297,604,380 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.1%
|
2,400,142
|
$278,416,472 | — | 30 Sep 2023 | |
| Redmile Group, LLC |
13F
|
Company |
6.8%
|
2,003,367
|
$232,390,572 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.8%
|
1,702,244
|
$197,460,304 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
3.5%
|
1,031,827
|
$119,691,932 | — | 30 Sep 2023 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
3.4%
|
988,460
|
$114,661,360 | — | 30 Sep 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2.4%
|
698,158
|
$80,986,328 | — | 30 Sep 2023 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
2.3%
|
671,311
|
$77,872,000 | — | 30 Sep 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.8%
|
520,637
|
$60,395,805 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
483,235
|
$56,062,490 | — | 30 Sep 2023 | |
| Hood River Capital Management LLC |
13F
|
Company |
1.6%
|
460,489
|
$53,416,724 | — | 30 Sep 2023 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.3%
|
373,812
|
$43,362,192 | — | 30 Sep 2023 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
1.2%
|
355,611
|
$41,250,876 | — | 30 Sep 2023 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.2%
|
340,849
|
$39,538,484 | — | 30 Sep 2023 | |
| Woodline Partners LP |
13F
|
Company |
1.1%
|
321,944
|
$37,345,504 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.98%
|
288,552
|
$33,472,032 | — | 30 Sep 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.89%
|
262,234
|
$30,419,144 | — | 30 Sep 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.87%
|
256,206
|
$29,721,000 | — | 30 Sep 2023 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.83%
|
244,061
|
$28,311,000 | — | 30 Sep 2023 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.79%
|
233,621
|
$27,100,036 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.75%
|
221,493
|
$25,693,188 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.72%
|
213,263
|
$24,738,508 | — | 30 Sep 2023 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.71%
|
209,487
|
$24,300,492 | — | 30 Sep 2023 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.67%
|
198,683
|
$23,047,228 | — | 30 Sep 2023 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.63%
|
185,809
|
$21,554,000 | — | 30 Sep 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.63%
|
184,344
|
$21,383,904 | — | 30 Sep 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.61%
|
179,780
|
$20,854,480 | — | 30 Sep 2023 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.58%
|
169,934
|
$19,712,344 | — | 30 Sep 2023 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.57%
|
167,485
|
$19,428,260 | — | 30 Sep 2023 | |
| Verition Fund Management LLC |
13F
|
Company |
0.43%
|
127,070
|
$14,740,120 | — | 30 Sep 2023 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.42%
|
123,035
|
$14,272,000 | — | 30 Sep 2023 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.4%
|
117,892
|
$13,675,472 | — | 30 Sep 2023 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.38%
|
112,800
|
$13,085,000 | — | 30 Sep 2023 | |
| Eversept Partners, LP |
13F
|
Company |
0.37%
|
108,771
|
$12,617,436 | — | 30 Sep 2023 | |
| S SQUARED TECHNOLOGY, LLC |
13F
|
Company |
0.37%
|
108,215
|
$12,552,940 | — | 30 Sep 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.33%
|
98,220
|
$11,393,520 | — | 30 Sep 2023 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.31%
|
90,560
|
$10,504,960 | — | 30 Sep 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.28%
|
83,635
|
$9,701,660 | — | 30 Sep 2023 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.27%
|
80,000
|
$9,280,000 | — | 30 Sep 2023 | |
| BRAIDWELL LP |
13F
|
Company |
0.26%
|
77,497
|
$8,989,652 | — | 30 Sep 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.25%
|
75,126
|
$8,714,616 | — | 30 Sep 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.24%
|
71,806
|
$8,329,496 | — | 30 Sep 2023 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.24%
|
71,531
|
$8,297,596 | — | 30 Sep 2023 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.24%
|
70,000
|
$8,120,000 | — | 30 Sep 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
0.24%
|
70,000
|
$8,120,000 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.21%
|
63,225
|
$7,334,100 | — | 30 Sep 2023 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.2%
|
57,500
|
$6,670,000 | — | 30 Sep 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.19%
|
55,757
|
$6,467,812 | — | 30 Sep 2023 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.19%
|
54,736
|
$6,349,376 | — | 30 Sep 2023 |
Institutional Holders of Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS) as of Q4 2023
As of 31 Dec 2023,
Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS) was held by
194 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,418,337 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, VANGUARD GROUP INC, FMR LLC, BlackRock Inc., Redmile Group, LLC, STATE STREET CORP, Frazier Life Sciences Management, L.P., JENNISON ASSOCIATES LLC, LORD, ABBETT & CO. LLC, and DIMENSIONAL FUND ADVISORS LP.
This page lists
194
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
187
Q4 2023 holders
194
Holder diff
7
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.